IP Library Granted Patent US 7,972,844
Granted Patent B2
US 7,972,844 · App. 11/354,560 · Granted Jul 5, 2011

Nuclear factor κB inducing factor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,972,844
App. No.
11/354,560
Granted
Jul 5, 2011
Kind
B2
Abstract

The present invention is directed to nuclear factor κB (NFκB)-inducing factor polypeptides (NFIF polypeptides) which are capable of inducing NFκB. The present invention includes within its scope NFIF polypeptides, including NFIF-14b and NFIF-7a, DNA, including cDNA, encoding these polypeptides, and expression vectors capable of expressing NFIF polypeptides. Also included are methods and compositions for increasing NFκB induction in a patient, methods and compositions for lowering NFκB induction in a patient, methods for inhibiting inflammation, and methods for manufacture of a medicament intended for the treatment and/or prevention of an NFκB-regulated inflammatory response. In addition, methods for determining whether a test compound inhibits or enhances the activity of NFIF polypeptides are provided.

Claims (4)

1. An isolated nucleic acid encoding NFIF-7a polypeptide comprising the amino acid sequence of SEQ ID NO:2.

2. The nucleic acid of claim 1 wherein said nucleic acid is a cDNA.

3. An expression vector comprising the isolated nucleic acid of claim 2 under the control of a promoter.

4. An isolated non-human host cell transformed or transfected with the expression vector of claim 3 .

Assignments (2)
MERGER Recorded Jan 19, 2015
From: AVENTIS PHARMACEUTICALS INC.
To: AVENTISUB LLC
Reel/Frame 034781/0334 →
CERTIFICATE OF CONVERSION Recorded Dec 9, 2014
From: AVENTISUB INC.
To: AVENTISUB LLC
Reel/Frame 034566/0976 →